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MAP2Ks are dual-specificity protein kinases func-
tioning at the center of three-tiered MAP kinase
modules. The structure of the kinase domain of the
MAP2K MEK6 with phosphorylation site mimetic
aspartic acid mutations (MEK6/DN/DD) has been
solved at 2.3 A˚ resolution. The structure reveals
an autoinhibited elongated ellipsoidal dimer. The
enzyme adopts an inactive conformation, based
upon structural queues, despite the phosphomimetic
mutations. Gel filtration and small-angle X-ray scat-
tering analysis confirm that the crystallographically
observed ellipsoidal dimer is a feature of MEK6/DN/
DD and full-length unphosphorylated wild-type
MEK6 in solution. The interface includes the phos-
phate binding ribbon of each subunit, part of the acti-
vation loop, and a rare ‘‘arginine stack’’ between
symmetry-related arginine residues in the N-terminal
lobe. The autoinhibited structure likely confers spec-
ificity on active MAP2Ks. The dimer may also serve
the function in unphosphorylated MEK6 of prevent-
ing activation loop phosphorylation by inappropriate
kinases.
INTRODUCTION
MAP kinase modules are three-tiered kinase cascades that
confer switch-like responses to extracellular and stress stimuli
in eukaryotes. The modules induce changes in cell program
and cell fate in processes such as differentiation, transformation,
apoptosis, and senescence (Chen et al., 2001; Deng et al., 2004;
Johnson and Lapadat, 2002; Pearson et al., 2001). MAP kinase
modules are chemically interesting because the central MAP
kinase kinases (MEKs) are dual specificity, phosphorylating a
Tyr and then a Ser/Thr residue to activate the MAP kinase (Hay-
stead et al., 1992). They are physically interesting because there
are numerous distinct MAP kinase modules whichmust maintain
pathway specificity. Of over a dozen MAP kinases in the
human genome, two of the best studied are the extracellular96 Structure 17, 96–104, January 14, 2009 ª2009 Elsevier Ltd All rigsignal-regulated kinase 1/2 (ERK1/2) and its activators MAP/
ERK kinases 1 and 2 (MEK1/2), and p38 MAP kinase isoforms
and their activators MEK6 and MEK3 (Raman et al., 2007). Other
well-studied pathways include the c-Jun N-terminal kinases
(JNKs) activated by MEK4 and MEK7, and ERK5 (Chen et al.,
2001), which is activated by MEK5. ERK1/2 are activated by
mitogens and growth factors (Raman et al., 2007; Yoon and
Seger, 2006). In contrast, p38 isoforms and MEK6 are activated
by bacterial liposaccharides, interleukins, tumor necrosis factor,
and cellular stresses such as osmotic shock and UV radiation
(Zarubin andHan, 2005). ERK5 andMEK5 appear to be activated
by a mixture of these signals (Wang and Tournier, 2006). Not
surprisingly, MAP kinase module components are drug targets
for several classes of diseases, including cancer, inflammation,
and degenerative diseases (Sebolt-Leopold and English, 2006).
How pathway fidelity is maintained in MAP kinase modules is
being intensively studied, and is now known to involve a variety
of docking and scaffolding interactions (Raman et al., 2007;
Tanoue and Nishida, 2003). Especially relevant to the present
study, it has been shown that docking motifs (D motifs) in the
N termini of MAP2Ks bind toMAPKs (Bardwell et al., 2003; Bard-
well, 2006). Further, a docking sequence in the C terminus of
MAP2Ks has been shown to mediate interactions with MAP3Ks
(Takekawa et al., 2005). This motif has been termed the DVD
motif, and in MEK6 encompasses the last 23 residues. Thus,
mammalian MAP2Ks bind both downstream MAPKs and
upstream MAP3Ks through docking interactions.
Structural data on MAP kinases are relatively abundant (Gold-
smith et al., 2007); structures of full-length inactive and active
forms of ERK2, p38 isoforms, and JNK isoforms reveal how
MAP kinases are activated by activation loop phosphorylation
(Bellon et al., 1999; Canagarajah et al., 1997; Wang et al.,
1997; Xie et al., 1998; Zhang et al., 1994). How docking interac-
tions are mediated in MAP kinases has also been studied (Chang
et al., 2002; Heo et al., 2004; Liu et al., 2006; Remenyi et al.,
2005; Zhou et al., 2006). Docking interactions both engage part-
ners and induce conformational changes that increase activation
loop accessibility. These conformational changes are likely to
contribute to pathway fidelity, because only kinases and phos-
phatases that have the right docking motif can unlock the activa-
tion loop for chemistry. Structures are also available for MAP3Ks
that reveal some aspects of their regulation by autoinhibition andhts reserved
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domain structures of B-Raf and TAO2 (Wan et al., 2004; Zhou
et al., 2004), and the RAS binding domain of B-Raf (Nassar
et al., 1995).
Despite the intrinsic interest in MAP2Ks as dual-specificity
kinases assuming a central role in MAP kinase modules, only
one structural study has been reported, on the ERK2 activators
MEK1/2 (Ohren et al., 2004). To find a fragment that would crys-
tallize, Ohren et al. made an N-terminal truncation eliminating the
MAPK binding D motif. The structures observed were unphos-
phorylated and inhibitor bound and clearly inactive (discussed
below). The MEK1/2 structures also revealed an unexpected
dimer. To learn more about the anatomy and regulation of
MAP2Ks, in this study we have determined the structure of the
MAP2K MEK6, one of the major activators of the p38a MAP
kinase (Han et al., 1996). Following the protocol of Ohren et al.,
we made an N-terminal truncation mutant deleting the D motif.
Further, we mutated the two phosphorylation sites of MEK6,
Ser207 and Thr211, to aspartic acid to mimic phosphorylation
(MEK6/DN/DD), in hopes of seeing the active form of a MAP2K.
However, the structure of this mutant reveals a novel autoinhibi-
tory dimer, despite the activating point mutations. The active site
is completely blocked in the dimer, and the activation loop is also
sequestered in the interface. Small-angle X-ray scattering (SAXS)
analysis and gel filtration reveal that dimers are formed byMEK6/
DN/DD and wild-type MEK6. We propose that the dimer interac-
tion presents a mechanism for regulation of both the activity and
activation of MEK6.
RESULTS
The construct used for crystallography in this study, MEK6/DN/
DD (residues 45–334 of MEK6), contains two phosphorylation
mimetic mutations in the activation loop (Ser207Asp and
Thr211Asp), and lacks the docking motif for substrate p38a (En-
slen et al., 2000). In the context of full-length MEK6, the aspartic
acid mutants confer activity toward its substrate p38a, as is the
case for MEK1/2 (Huang et al., 1995). The turnover numbers for
full-length MEK6/DD and wild-type doubly phosphorylated full-
length MEK6 are 12.8 ± 0.6 and 8.0 ± 0.1, respectively (J.M.H.
and E.J.G., unpublished data).
The structure was solved by single-wavelength anomalous
dispersion (SAD) from a complete data set collected on a single
selenomethionine-incorporated protein crystal and refined
against 2.35 A˚ resolution X-ray data. The final structure was
refined in REFMAC5 (Murshudov et al., 1997) to an R factor of
19.6% (Rfree 24.7%) with reasonable stereochemistry (Table 1).
The protein crystallized in space group P3221, with four subunits
in the asymmetric unit. The four subunits form two tight dimers
shown in Figure 1A (left panel). One of the two dimers is shown
in the right panel of Figure 1A. The individual chains are very
similar. In all the four chains, part of the activation loop
(Val208–Cys216) is disordered. A TLS refinement was performed
with four TLS parameters per chain (Painter and Merritt, 2006).
The B factors were uniformly elevated, indicative of motion of
the individual chains. Nevertheless, the pairwise root-mean-
square deviation (rmsd) ranged between 0.6 and 0.8 A˚ among
the four subunits. The model contains 1111 residues, 4 sulfate
ions, and 331 water molecules.Structure 17,The MEK6 Monomer Structure
MEK6 belongs to the STE group of protein kinases (Manning and
Davis, 2003), and the MEK6/DN/DD construct used is similar in
length to another STE group kinase, TAO2 (TAO2 [1–320]), the
structure of which was solved in an active conformation (Zhou
et al., 2004). As with TAO2, the MEK6/DN/DD subunit adopts
a bilobal fold, similar to other protein kinases (Jones et al.,
1997; Knighton et al., 1991) (Figure 1B), with two additional
helices (J and K) at the C terminus. The N-terminal lobe of
MEK6/DN/DD is composed of a b sheet and one long helix (helix
C); the C-terminal lobe is helical. Comparison of MEK6 to active
TAO2 reveals dramatic differences, suggestive that MEK6
adopts an inactive structure despite the phosphomimetic muta-
tions. As in protein kinases generally, the N-terminal lobe b sheet
of TAO2 consists of five strands (Figure 1B). (The first two
strands of the b sheet are also referred to as the ATP phosphate
binding ribbon, or P loop; Jones et al., 1997.) In contrast to TAO2,
the phosphate binding ribbon inMEK6 is formed into a large loop
between Ile56 and Glu68, reminiscent of an U loop (Leszczynski
and Rose, 1986). At the C terminus of this U loop, Glu68 makes
an ion pair with the catalytic lysine (Lys82) in b strand 3.
The activation loop of MEK6/DN/DD exhibits hallmarks of a
kinase-inactive conformation. The DFG motif (subdomain VII)
at the beginning of the activation loop adopts a modified DFG-
out configuration, which is present in some inactive kinases
and inhibitor complexes (Wrobleski and Doweyko, 2005)
(Figure 1B). Asp197 of the DFG occupies the pocket normally
Table 1. Statistics of Crystallographic Data and Refinement
Space group P3221
Unit cell dimensions (A˚) a = b = 122.66, c = 195.54
Wavelength (A˚) 0.97905
Resolution (A˚) 202.35
Number of unique reflections 71,376
Average multiplicity (last shell) 6.6 (6.4)
Completeness (%) (last shell) 99.9 (99.9)
Intensity I/sI (%) 35/1.7
Rsym (last shell)
a 0.07 (0.68)
Rwork/Rfree
b 0.206/0.257
Nonhydrogen protein atoms 8,835
Waters 331
Rmsd in bond length (A˚)c 0.02
Rmsd in bond angles ()c 2.00
Average B values (A˚2) 57.2
Ramachandran plot statistics (%)
Residues in most favored region 89.1
Residues in additionally allowed region 9.1
Residues in generously allowed region 1.8
Residues in disallowed region 0.0
aRsym =
PjIavg  Ijj/
P
Ij.
b R factor =
PjFo  Fcj/
P
Fo, where Fo and Fc are observed and calcu-
lated structure factors, respectively, Rfree was calculated from a randomly
chosen 5% of reflections excluded from the refinement, and Rwork was
calculated from the remaining 95% of reflections.
c Rmsd is the root-mean-square deviation from ideal geometry.96–104, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 97
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The Structure of the MAP2K MEK6Figure 1. The Structure of MEK6/DN/DD
(A) The left panel shows the two dimers in the asymmetric unit; the right panel shows one of the crystallographic dimers. The twomonomers are in yellow and pink.
The disordered activation loop is shown as a dotted line.
(B) Amonomer is depicted with the side chains of residuesGlu68, Lys82, Asp99, Asp197, Phe198, and Tyr203 in ball and stick representation. The TAO2 structure
in the same orientation is shown here for comparison. The red box highlights the U loop in MEK6/DN/DD and compares it with the b1 strand and the b2 strand
enclosed in a red box in TAO2.
(C) Close-up view of the C terminus, helices J and K. Residues in the DVDmotif are shown as blue spheres, His317, Thr322, Val324, Phe327, Val328, and Ile331.
We mutated the residues in the dimer interface, Asp124, Tyr64, Arg83, Arg61, Leu59, and Tyr203 (shown as orange spheres) to alanine. Leu332 (green sphere) is
in the DVD motif and was also mutated. Note that the second subunit of the dimer is nearby (in yellow).
(D) Close-up view of the activation loop and PYMAPER loop in the same color scheme as in (A). Arg178, Asp179, Lys181, Pro218, Tyr219, Leu229, and Arg224.
Drawn in PyMOL (DeLano, 2002).98 Structure 17, 96–104, January 14, 2009 ª2009 Elsevier Ltd All rights reserved
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The Structure of the MAP2K MEK6held by Phe198, and accepts a hydrogen bond from a serine in
helix C, Ser103 (not shown). Residues Ile200–Tyr203 of the acti-
vation loop make one turn of helix (Figures 1B). This helix,
together with Phe198 of the DFG, is wedged between the
N-terminal lobe b sheet and helix C. The location of this helix
prevents the formation of an ion pair between the catalytic
Lys82 in b strand 3 and Asp99 from helix C, expected for an
active kinase (Huse and Kuriyan, 2002). Similarly in MEK1/2,
the small helix at the N terminus of the activation loop also
disrupts the Lys-Asp ion pair (Ohren et al., 2004). The last residue
of the activation loop that is fully visible is Ser207Asp (phos-
phomimetic mutation to aspartic acid). The activation loop is
disordered from Val208 through Cys216, including the phos-
phorylation site Thr211Asp (mutated to aspartic acid). In active
kinases, Cys216 would be expected to contact the catalytic
loop residues Asp171 and Lys181 (Goldsmith et al., 2007), but
is instead disordered. The other residues in the activation loop,
Lys217, Pro218, and Tyr219, are visible, but deviate from ex-
pected positions (see Figure 1C). The degree of remodeling of
the C terminus of the activation loop is similar to that of inactive
PAK1, another STE group kinase (Lei et al., 2000; Zhou et al.,
2004).
In the C-terminal lobe, following the kinase-conserved helix I,
MEK6 has two further helices, J and K, that extend nearly to the
C terminus of the chain and pack against the kinase core. The
Figure 2. The Dimer Interface
(A) Stereo view of the two U loops bound to the
opposite subunit active sites, and contacts with
the C terminus. Two subunits are shown, and
rendered in cartoon. Side chains of Leu59,
Arg61, Tyr64, and Leu332, and the backbone of
Gly60 and Arg61, are rendered for both mono-
mers. Dotted lines denote hydrogen bonds (2.8–
3.0 A˚).
(B) View of a 180 rotation about Y from (A)
showing the arginine stack. Arg83, Ala86,
Asp124, and Trp126 are rendered in ball and stick
representation. Electron density contoured at 1s
covers selected side chains.
first helix (J), residues Pro312–Lys320,
packs across helix E and the second helix
(K), residues Val324–Leu332, binds in the
groove between helices D and E in the b7-
b8 hairpin turn (Figure 1B). (In MAPKs, the
homologous groove binds D motifs.) The
last two residues (Gly334 and Asp335),
which are conserved in the MEK3/6
subgroup, are not visible in the electron
density. Helices J and K adopt nearly
identical positions to the same helices in
MEK1/2 (Ohren et al., 2004). The DVD
docking site in MAP2Ks that mediates
interactions with MAP3Ks (Takekawa
et al., 2005) encompasses part of helix
J and all of helix K. Takekawa et al.
showed that His317, Thr322, Val324,
Phe327, Val328, and Ile331 of MEK6
(shown as blue balls in Figure 1D) affect interactions with
MAP3Ks, including TAO2, when mutated. Leu332 (green ball),
which follows these DVD residues, also forms contacts in the
subunit interface (discussed below).
The structure offers clues concerning the residues likely to
be involved in recognition of the activation loop Ser/Thr phos-
phorylation sites of MAP2Ks in their phosphorylated active
configuration. Following the activation loop (and P+1 site), sub-
domain VIII of MAP2Ks has a conserved motif PYMAPER. The
arginine at the terminus of this sequence, Arg224, is unique to
MAP2Ks. Here we observe that it is nearby Arg178 in subdomain
IV (Figure 1D), the conserved arginine involved in phosphothreo-
nine or phosphotyrosine binding in active kinases (Hubbard,
1997). Thus, this arginine may be involved in S*/T* recognition
in MEK6/S*T*. Another feature is that the residues forming the
loop between 218PYMAPER224 and helix F (Asn226–Ser235)
are not tightly packed on the kinase core, and Leu229 faces
solvent, creating an open conformation of the loop between
the PYMAPER motif and helix F. This extended structure arises
from an insert of three residues in the MEK6/MEK3 subgroup,
as discussed below.
The MEK6 Dimer Interface
The four subunits of the crystallographic asymmetric unit form
two very similar two-fold symmetric tight dimers (left panel ofStructure 17, 96–104, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 99
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The Structure of the MAP2K MEK6Figure 1A). The dimer brings the N termini of the two subunits
together, creating an elongated ellipsoid (right panel of Figure 1A)
that buries 1500 A˚2 of surface. In the interface, the distorted U
loop-shaped phosphate binding ribbon of one subunit binds in
the ATP binding site of the opposite subunit (Figures 1B and
2A). Tyr64, which in active kinases is at the apex of the phos-
phate binding ribbon, occupies the nucleotide binding site of
the opposite subunit. The backbone carbonyl groups of Tyr64
and Ala63 accept hydrogen bonds from the catalytic Lys820Nz
(0 denotes second subunit), and the nitrogen atom in Val67
makes a hydrogen bond to the side-chain oxygen atom (Od1)
in Asp2060 in the activation loop. The U loop also make contacts
with the opposite C terminus, where Leu590 contacts Leu332
(Figure 2A). Weak hydrogen bonds also link the U loop and the
crossover connection at the back of the active site (not shown).
Overall, the interactions between the two subunits appear to
both render the protein inactive and limit the accessibility of
the activation loop phosphorylation sites (blue spheres in
Figure 1A) toward other kinases or phosphatases.
The dimer interface also involves the linker between b strand 3
and helix C and the loop between b strand 4 and b strand 5 (Fig-
ure 2A). An unusual ‘‘arginine stack’’ is found in the center of this
interaction (Figure 2B). Arg83, which is located at the end of
b strand 3, stacks with its symmetry mate. This arginine stack
is stabilized by ion-pair interactions with Asp1240 from the loop
between b strand 4 and b strand 5 of the opposite subunit (and
the symmetry-related interaction between Arg830 and Asp124).
Arginine stacks are rare in protein structures but are thought to
Figure 3. Low-Angle X-Ray Scattering of
MEK6/DN/DD
(A) Buffer-subtracted scattering profile (black) of
MEK6/DN/DD is consistent with an extended
conformation. The fit to the experimental data of
one ab initio DAMMIN model is shown in red.
(B) The electron-pair distribution function of the
experimental data shows a general bell-shaped
curve, but with an asymmetric bias toward the
longer distances, indicating an extended struc-
ture. Dmax was 140 A˚.
(C) Data in the Guinier region are linear, indicating
monodispersity of the sample in solution.
(D) Averaged and filtered ab initio shape predic-
tion for MEK6/DN/DD in solution was calculated
by the program DAMMIN and aligned using the
DAMAVER program suite. The overall volume is
consistent with two molecules of MEK6/DN/DD
and the crystallographically observed dimer.
Figure 4. Analytical Gel Filtration of MEK6/
DN/DD
Comparison of elution volumes from analytical gel
filtration (Superdex 200 10/300) of MEK6/DN/DD
in the presence (red) and absence (green) of ATP
in the column buffer and a double mutant
D124A/W126S (blue). A shift toward lower molec-
ular weight in the presence of ATP and for the
double mutant indicates a change in dimer-
monomer equilibrium.
100 Structure 17, 96–104, January 14, 2009 ª2009 Elsevier Ltd All rights reserved
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The Structure of the MAP2K MEK6stabilize interactions (Magalhaes et al., 1994). An arginine stack
very similar to this one was recently found to be involved in the
synaptotagmin switch mechanism (Fuson et al., 2007).
MEK6 Oligomerization in Solution
To obtain information on the molecular envelope and state of
oligomerization in solution, SAXS was performed on MEK6/DN/
DD at the SIBYLS beamline at the Advanced Light Source (Put-
nam et al., 2007; Tsutakawa et al., 2007). The shape of the scat-
tering curve and electron-pair distribution (Figures 3A and 3B)
are consistent with an elongated ellipsoid (Koch et al., 2003).
The Guinier plots were linear, an indication of monodispersity
of the sample (Figure 3C). The radius of gyration from the
GNOM analysis was 38 A˚. Based on the data below, the scat-
tering vector q = 0.2 A˚1, the Porod volume (hydrated volume)
for MEK6/DN/DD is 132,000 A˚3, providing an approximate
molecular mass of 79,000 Daltons. The calculated molecular
weight of each MEK6/DN/DD including the N-terminal hexa-
His tag is approximately 36 kDa. Thus, the Porod volume is
consistent with a dimer. Further, ab initio analysis in P1
symmetry by the programDAMMIN revealed an elongated struc-
ture (Figure 3D) of the same volume. The apparent P2 symmetry,
Figure 5. Comparisonof Dimer Interface betweenMEK6andMEK1/2
(A) Sequence alignments of MAP2Ks in regions forming the dimer interfaces in
MEK6 and MEK1/2.
(B) The MEK6 (present work) and MEK1/2 (Ohren et al., 2004) (Protein Data
Bank ID code IS9J) dimers are shown with the conserved residues rendered
as balls. A cartoon representation shows the differences in packing of the
dimers in the two MAP2Ks.Structure 17, 9when no symmetry was enforced, is again consistent with
a dimer.
Both MEK6/DN/DD and full-length MEK6 also elute as dimers
on a Superdex 75 16/60 gel-filtration column (elution volume
58 ml). ATP (1 mM) in the column buffer causes the elution
volume to increase (Figure 4), as observed by analytical gel filtra-
tion through Superdex 200 10/300, suggestive of a change in the
dimer-monomer equilibrium within a physiologically relevant
concentration range (Gribble et al., 2000;Marjanovic et al., 1993).
The Sequence Conservation of the Subunit Interface
A multiple sequence alignment of MAP2Ks given in Figure 5A
revealed that many residues in the observed MEK6 dimer are
conserved in the MEK6/MEK3 subgroup, but are not conserved
in MEK1/2. Tyr64, Arg83, Asp124, and Leu332 are conserved
residues in the interface. Further, Tyr203, in the activation loop
and interface, is conserved in theMEK3/6 subgroup. Single point
mutations of the conserved residues (orange balls in Figure 1D)
in the interface, including Arg83 involved in the arginine stack
(discussed above), did not show any strong effect on the dimer.
A double mutant, D124A/W126S, was synthesized, which
showed a slight change in the elution volume on a Superdex
200 10/300 gel-filtration column, indicative of a shift toward a
monomer (Figure 4). We also tested the activity of these MEK6/
DN/DD mutants toward p38a and found that none of them
rescued the low activity ofMEK6/DN/DD (data not shown). These
data further support the idea that the docking motif of MEK6 is
required for activity toward its substrate MAPK (Bardwell, 2006).
Comparison of MEK6 with MEK1/2
Crystallographic studies of MEK1/2 were on inactive, unphos-
phorylated MEK1/2 (Ohren et al., 2004). There are several inter-
esting parallels between inactive MEK1/2 (N-terminal truncation
mutant) and MEK6/DN/DD, however. First, there are similarities
in secondary structure arrangements. The activation loops of
both are formed into a small helix that makesmost of its contacts
with the N-terminal lobe, between the b sheet and helix C. The
placement of Arg224 in the PYMAPER sequence is similar in
both structures, in close proximity to the phosphorylation sites
in active kinases (Figure 1D). In MEK1/2, the loop following the
PYMAPER sequence is shorter by three residues and not quite
as extended as in MEK6. At the C terminus, MEK1/2 have very
similar C-terminal helices (J and K). On the other hand, MEK1/2
have a normal phosphate binding ribbon, in contrast to the U
loop observed in MEK6/DN/DD.
A second similarity is that both MEK6 and MEK1/2 form
dimers. However, the dimers are mediated by completely
different contacts (Figure 5B). In MEK6, most of the interactions
are between the N-terminal domains, as discussed above,
whereas in MEK1/2, the interface is near helix G and the activa-
tion loop. Further, the MEK6 dimer adopts an antiparallel config-
uration, whereas MEK1/2 form a parallel configuration. Residues
that form the interfaces are conserved in each subgroup
(Figure 5A) but not between subgroups. In the MEK1/2 dimers,
access to the active site is blocked for macromolecules,
although not for small molecules. Further access to the activa-
tion loop by macromolecules is also partially restricted in
MEK1/2. These data suggest similar roles for the MEK1/2 and6–104, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 101
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site processing by kinases and phosphatases.
DISCUSSION
Recent structural studies have revealed that many protein
kinases form distinctive higher-order assemblies with altered
activities. For example, two recent studies, one on EGFR (Zhang
et al., 2006) and the another on antiviral protein kinase PKR (Dey
et al., 2005), implicate dimerization in the activation mechanism.
Our data suggest that MEK6 forms an autoinhibitory dimer in the
absence of its own substrates or other interacting partners. The
elongated ellipsoidal dimer observed crystallographically for
MEK6/DN/DD was also found for full-length wild-type MEK6 in
SAXS analysis, showing that the dimer is a feature of full-length
MEK6. The primary function of the autoinhibitory dimer may be
to maintain MEK6 in an inactive form in the absence of its
substrates. So far, it is unclear how the dimer is broken by
substrate interactions. The dimer may also have a role in restrict-
ing the activation of MEK6. The MEK6 activation loop, although
partially disordered, is surrounded by protein and is inaccessible
to macromolecules. The docking motif (DVD motif) for MAP3Ks
identified by Takekawa et al. (2005) is at the C terminus of MEK6.
Because theC-terminal residue Leu332 is in thedimer interface, it
is apparent that interactions with a MAP3K should disrupt the
MEK6 dimer, thus perhaps making the activation loop of MEK6
more available for processing byMAP3K. Thus, it is possible that
this inactive dimer has a role both in the phosphorylated and un-
phosphorylated forms. In the active phosphorylated form, it
restricts access to inappropriate substrates. In the unphosphory-
lated form, it prevents activation by inappropriate kinases.
It is interesting that MEK1/2/DN, inhibitor bound and unphos-
phorylated, also form dimers. Although the interface is
completely different fromMEK6 (Ohren et al., 2004), the MEK1/2
dimers also block access of the substrate binding site and the
activation loop from macromolecules, perhaps again having
a role in regulating both activity and activation. It is intriguing in
this regard that in both MEK1/2 and MEK6, the phosphorylation
sites are in the dimer interface but not visible in these inactive
dimers. Because the MEK1/2 study was done on unphosphory-
lated MEK1/2 and our study was done with phosphorylation site
mimetics, apparently the stability of the dimers may not depend
on phosphorylation status in either case.
This autoinhibitory dimer of MEK6, and by inference MEK1/2
dimers, add to a growing list of unanticipated allosteric regula-
tory mechanisms that confer pathway specificity in MAP kinase
modules and other protein kinases (Goldsmith et al., 2007; Bi-
ondi and Nebreda, 2003). Crystal structural studies from several
laboratories, including ours, previously showed that the docking
interaction between MAP2Ks and MAPKs works allosterically to
make the activation loop of MAPKs available for processing by
kinases and phosphatases (Chang et al., 2002; Zhou et al.,
2006). Here we see that MAP2K adopts an inactive configuration
in the absence of its substrates, and again the activation loop is
sequestered from the action of inappropriate kinases and phos-
phatases. The autoinhibited dimer observed for MEK6 is also
reminiscent of the phenomenon of autoinhibition in MAP3Ks
mediated by regulatory domains (Takekawa et al., 2005). We
look forward to more data on the significance of dimerization102 Structure 17, 96–104, January 14, 2009 ª2009 Elsevier Ltd All rto the activity of MAP2Ks in the context of full-length wild-type
proteins, and to fully exploring the role of individual residues in
the dimer-monomer equilibrium.
EXPERIMENTAL PROCEDURES
Protein Expression and Crystallization
Human MEK6 (residues 45–334) was cloned into a pHisParallel vector using
NcoI and SpeI sites (Sheffield et al., 1999). Point mutations Ser207Asp and
Thr211Asp and others were introduced using a QuikChange kit (Stratagene).
The MEK6/DN/DD protein was expressed in Rosetta 2 cells (Novagen). The
cells were induced with 0.5 mM IPTG at OD 0.7 and the protein was expressed
for 12 hr at 18C. Cells were lysed in two passes through an Avestin cell
disruptor. The lysate was cleared by centrifugation at 35,000 3 g for 1 hr.
The supernatant was applied to an Ni Sepharose column (GE Life Sciences)
precharged with 0.1 M NiSO4 and protein was eluted with 250 mM imidazole.
The protein was further purified by anion-exchange chromatography on
a MonoQ HR 5/5 column (GE Life Sciences) using a linear gradient and size-
exclusion chromatography on a Superdex 75 16/60 column (GE Life Sciences).
The final buffer was 30 mM HEPES, 100 mM NaCl, 1 mM EDTA, 1 mM DTT,
1 mM TCEP (tris[2-carboxyethylphosphene]; Sigma). Protein was concen-
trated to 12 mg/ml using an Amicon concentrator. Prior to crystallization trials,
0.05% b-octyl glucoside was added. The selenomethionine-incorporated
protein was expressed in met auxotrophic strain B834 (Novagen) grown in
minimum media supplemented with selenomethionine and other nutrients
(Doublie et al., 1994) and purified using the same protocol as the native protein.
The crystals of both native protein and selenomethionine-incorporated protein
were grown using the hanging-dropmethod. The well solution contained 1.6M
Li2SO4 and 0.1 M Tris (pH 8.0). The crystals reached 0.2 3 0.2 3 0.15 mm in
1 week. The crystallization drop was supplemented with 20% glycerol and
the crystals were frozen in liquid propane before data collection.
Data Collection and Structure Solution
A single-wavelength anomalous data set for the selenomethionine-
incorporated protein crystal was collected at beamline 19-BMat the Advanced
Photon Source at Argonne National Laboratory. The data were integrated and
scaled using the HKL2000 program (Otwinowski and Minor, 1997). Thirty-nine
out of 48 possible selenomethionine sites were located using the program
SHELXD (Schneider and Sheldrick, 2002). The phases were improved further
by solvent flattening using the CNS program (Brunger et al., 1998). The initial
model was constructed using a combination of manual tracing and Arp/
wARP auto tracing (Perrakis et al., 1999). The model was refined using the
program REFMAC5 (Murshudov et al., 1997) in the CCP4 software suite
(CCP, 1994), followed by iterative rounds of manual building with the
program O (Jones et al., 1991). Within REFMAC5, rigid-body refinement was
carried out separating the domains between Glu130 and Leu131 of the four
monomers in the asymmetric unit. The final structure was refined to an R factor
of 19.6% (Rfree 24.7%).
Small-Angle X-Ray Scattering
SAXS data were collected on MEK6/DN/DD, purified by gel filtration, on the
SIBYLS beamline at the Advanced Light Source at Lawrence Berkeley
National Laboratory with a Mar165 CCD detector. Scattering data were
collected with 1.11587 A˚ wavelength X-ray radiation, and processed by the
Svergun software suite (Svergun et al., 2001). Three protein concentrations
(10, 5, and 2.5 mg/ml) and the equivalent gel-filtration buffer were exposed
for 7 and 70 s at room temperature. The program OGRE was used to subtract
protein from buffer frames taken for the same length of exposure and account
for the sample-detector distance and wavelength. Guinier analysis detected
a small but significant radiation sensitivity that caused eventual sample aggre-
gation, so only the first short exposure was used for analysis. The most
concentrated sample, with the best signal-to-noise ratio, was superimposable
on lower concentrations. These data were processed with PRIMUS of the
ATSAS 2.1 suite (Svergun et al., 2001) for the Guinier and Porod analyses.
These data were further processed using the regularization technique in
GNOM, in which the pairwise electron distribution function (Patterson function)
was obtained from the transform of the scattering function with a Dmax of 140ights reserved
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The Structure of the MAP2K MEK6A˚. Ten ab initio shape determination runs were done using DAMMIN (Svergun
et al., 2001), which does not require input of the molecular mass and therefore
is independent of user bias. The chi**2 from the DAMMIN log files (1.031–
1.033) reflect a good match of the individual ab initio shape predictions to
the scattering curves. Averaged outputs of the ten runs were filtered using
DAMAVER (Svergun et al., 2001). Models were superimposable with the
observed DAMFILT shape shown in Figure 3D.
Kinase Assays
The phosphorylation of p38a and myelin basic protein (MBP) by various MEK6
enzymes was conducted using the standard [g-32P]ATP kinase assay condi-
tions. All kinase assays were carried out under the standard conditions of
20 mM HEPES (pH 7.4), 20 mM MgCl2, 2.5 mM ATP, and substrate in a final
volume of 100 ml at 30C. For radiolabeled products, 5–10 mCi of [g-32P]ATP
per reaction was mixed with the cold ATP. All reactions were initiated by the
addition of enzyme after equilibration for 5 min at 30C.
Typical assays used 20 pmol of MEK6 and 2500 pmol of p38a or 2000 pmol
of MBP. Assay termination and phosphorylation measurement were accom-
plished using protocols described previously (Braun et al., 1984; Racker,
1991). Reactions were terminated at desired time points by spotting aliquots
on 3MM filter paper followed by immediate immersion in termination solution
(10% trichloroacetic acid and 10 mM pyrophosphate). Washing with fresh
termination solution was followed by autoradiography.
ACCESSION NUMBERS
The coordinates of MEK6/DN/DD have been deposited in the Protein Data
Bank under ID code 3ENM.
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